Search | IOVS | ARVO Journals

View

Showing 1 – 14 of 14

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Clinical characteristics and gene expression profile status in young patients with uveal melanoma: Collaborative Ocular Oncology Group study #2 (COOG2) study

Ekaterina Semenova; Christina Decatur; Amy C Schefler; Thomas Aaberg; Brian Marr; Zelia Correa; J. William Harbour; Prithvi Mruthyunjaya; Miguel Materin

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):39. doi:

ARVO Annual Meeting Abstract June 2021

Design, Methods, and Rationale for the Collaborative Ocular Oncology Group 2 (COOG2) Study

Amy C Schefler; Prithvi Mruthyunjaya; Christina Decatur; Miguel Materin; Zelia Correa; Thomas Aaberg; Brian Marr; Katya Semenova; J. William Harbour

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2870. doi:

ARVO Annual Meeting Abstract June 2020

Interim analysis of small choroidal melanocytic tumors with and without identifiable driver mutations

Ezekiel Weis; Prithvi Mruthyunjaya; Amy C Schefler; Zelia Correa; Thomas M Aaberg; Michael Durante; Christina Decatur; J William Harbour

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2847. doi:

ARVO Annual Meeting Abstract July 2019

Addressing Disparities in Hispanic Patients with Uveal Melanoma Using Global and Local Ancestry Analysis

Daniel Rodriguez; Margaret I Sanchez; Christina Decatur; J. William Harbour

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):758. doi:

ARVO Annual Meeting Abstract July 2019

Class 2 metastasizing uveal melanomas arise through BAP1 loss and epigenetic reprogramming to a migratory neural crest-like state

Matthew Field; Parker Bussies; Louie Cai; Christina Decatur; Jeffim Kuznetsov; Stefan Kurtenbach; J. William Harbour

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):957. doi:

ARVO Annual Meeting Abstract March 2012

Intravitreal Bevacizumab As An Adjuvant Agent To Plaque Brachytherapy Reduces Tumor Burden And Enhances The Resolution Of Exudative Detachment

Samuel K. Houston; Nisha Shah; Christina L. Decatur; Marcela Lonngi; William J. Feuer; Timothy G. Murray

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3425. doi:

ARVO Annual Meeting Abstract March 2012

2-deoxy-D-glucose (2-DG): In vivo Evaluation of Anti-angiogenic Impact on Retinoblastoma Tumor Vasculature

Nikesh N. Shah; Samuel Houston; Yolanda Piña; Timothy G. Murray; Christina L. Decatur; Jaime Merchan; Theodore Lampidis

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1873. doi:

ARVO Annual Meeting Abstract March 2012

Use of AMP-kinase Activator 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) in the Treatment of Retinoblastoma

Christina L. Decatur; Nikesh Shah; Yolanda Piña; Marcela Lonngi; Dien Pham; Samuel Houston; Timothy G. Murray

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1875. doi:

Anatomy and Pathology/Oncology February 2012

Retinoblastoma Treatment: Utilization of the Glycolytic Inhibitor, 2-deoxy-2-fluoro- d -glucose (2-FG), to Target the Chemoresistant Hypoxic Regions in LH BETA T AG Retinal Tumors

PDF

Yolanda Piña; Christina Decatur; Timothy G. Murray; Samuel K. Houston; Milena Lopez-Cavalcante; Eleut Hernandez; Magda Celdran; Nikesh Shah; William Feuer; Theodore Lampidis
TAGS: glucose, hypoxia, neoplasms, retinal neoplasms, retinoblastoma
Invest. Ophthalmol. Vis. Sci.. 2012; 53(2):996-1002. doi: https://doi.org/10.1167/iovs.11-8265

ARVO Annual Meeting Abstract April 2011

Mammalian Target Of Rapamycin In Combination With Chemotherapy: Upstream Regulation Of Anaerobic Glycolysis To Target The Chemoresistant Cell Population In Retinoblastoma

Yolanda Pina; Christina Decatur; Samuel Houston; Ludimilla Cavalcante; Theodore Lampidis; Timothy Murray

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2484. doi:

ARVO Annual Meeting Abstract April 2011

A Novel, Oral, Non-invasive Method Of Delivery For The Glycolytic Inhibitor 2-deoxy-d-glucose In The Treatment Of Retinoblastoma

Timothy G. Murray; Christina Decatur; Yolanda Piña; Samuel Houston; Ludimilla Cavalcante; Theodore Lampidis

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1592. doi:

ARVO Annual Meeting Abstract April 2011

Evaluating the Glycolytic Pathway in Retinoblastoma: A Molecular Mechanistic Approach Using the Glycolytic Inhibitor 2-deoxy-D-glucose in vitro and in vivo

Christina L. Decatur; Yolanda Pina; Samuel Houston; Ludimila Cavalcante; Timothy Murray; Theodore Lampidis

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2483. doi:

ARVO Annual Meeting Abstract April 2011

Use of 2-fluorodeoxy-d-glucose (2-FDG) to Target the Chemoresistant, Hypoxic Cell Population in Advanced LHBetaTAg Retinal Tumors

Samuel K. Houston; Timothy G. Murray; Christina L. Decatur; Yolanda Pina; Ludimila Cavalcante; Theodore Lampidis

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2487. doi:

ARVO Annual Meeting Abstract April 2011

Characterization of Transgenic Mouse RPE Cultures

Nicole R. Congrove; Christina L. Decatur; J. Brett Stanton; Alan D. Marmorstein; Brian S. McKay

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):931. doi:

Advertisement